Advances in research on the effects of medicinal and edible substances on lung cancer: an updated review

Lung cancer, as one of the malignant tumors with the highest morbidity and mortality worldwide, poses a serious threat to human life and health. Despite the fact that there have been significant advances in the modern medicine treatment of lung cancer, the problem of drug resistance and the potential toxic side effects associated with the respective treatment still restrict the clinical efficacy and the amelioration of patients'quality of life. Based on this background, the therapeutic value of traditional Chinese medicine (TCM) as an adjuvant has become increasingly prominent. Among these, medicinal and edible substances have garnered growing research attention for the adjuvant treatment of lung cancer, owing to their wide sources, fewer side effects, and multi-pathway anti-tumor potential. Medicinal and edible substances abound with polysaccharides, flavonoids, terpenoids, saponins, polyphenols, and other bioactive substances. They are pivotal in the prevention and treatment of lung cancer through multiple mechanisms, including anti-inflammatory effects, antioxidant effects, immunomodulation effects, inhibition of tumor angiogenesis effects, and cell regulation effects. In this review, the pharmacological action of active components in medicinal and edible substances and the mechanism of action in the treatment of lung cancer were reviewed systematically, and the research direction of medicinal and edible substances in the field of lung cancer in the future was prospected, in an effort to provide theoretical reference for promoting its in-depth application in the comprehensive treatment of tumors, as well as for its complementarity of strengths and coordinated advancement with modern medicine.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-01-22
DOI
https://doi.org/10.3389/fphar.2025.1735406
Primary Topic
Flavonoids in Medical Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advances in research on the effects of medicinal and edible substances on lung cancer: an updated review

Yuan Yang, K Li, Jinhua Wang, Genming Zhang et al.
Frontiers in Pharmacology
Flavonoids in Medical Research
article

Advances in research on the effects of medicinal and edible substances on lung cancer: an updated review

Yuan Yang, K Li, Jinhua Wang, Genming Zhang, Lingli Jiang, Daorui Li
article en

Abstract

Lung cancer, as one of the malignant tumors with the highest morbidity and mortality worldwide, poses a serious threat to human life and health. Despite the fact that there have been significant advances in the modern medicine treatment of lung cancer, the problem of drug resistance and the potential toxic side effects associated with the respective treatment still restrict the clinical efficacy and the amelioration of patients'quality of life. Based on this background, the therapeutic value of traditional Chinese medicine (TCM) as an adjuvant has become increasingly prominent. Among these, medicinal and edible substances have garnered growing research attention for the adjuvant treatment of lung cancer, owing to their wide sources, fewer side effects, and multi-pathway anti-tumor potential. Medicinal and edible substances abound with polysaccharides, flavonoids, terpenoids, saponins, polyphenols, and other bioactive substances. They are pivotal in the prevention and treatment of lung cancer through multiple mechanisms, including anti-inflammatory effects, antioxidant effects, immunomodulation effects, inhibition of tumor angiogenesis effects, and cell regulation effects. In this review, the pharmacological action of active components in medicinal and edible substances and the mechanism of action in the treatment of lung cancer were reviewed systematically, and the research direction of medicinal and edible substances in the field of lung cancer in the future was prospected, in an effort to provide theoretical reference for promoting its in-depth application in the comprehensive treatment of tumors, as well as for its complementarity of strengths and coordinated advancement with modern medicine.

Frontiers in PharmacologyVol. 16
Beijing University of Chinese Medicine (CN), China Academy of Chinese Medical Sciences (CN), Guang’anmen Hospital (CN)
National Natural Science Foundation of China, China Academy of Chinese Medical Sciences, National Health Commission of the People's Republic of China
Good health and well-being
Openalex Percentile: Top 79%
Flavonoids in Medical Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.